ASSEMBLY BIOSCIENCES INC's ticker is ASMB and the CUSIP is 045396108. A total of 41 filers reported holding ASSEMBLY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,682 | -23.0% | 108,116 | 0.0% | 0.00% | – |
Q2 2023 | $124,334 | +50.4% | 108,116 | +9.9% | 0.00% | – |
Q1 2023 | $82,695 | -30.5% | 98,400 | +7.6% | 0.00% | – |
Q4 2022 | $118,914 | -21.2% | 91,472 | -0.4% | 0.00% | – |
Q3 2022 | $151,000 | -19.3% | 91,804 | +3.0% | 0.00% | – |
Q2 2022 | $187,000 | -2.1% | 89,130 | -3.9% | 0.00% | – |
Q1 2022 | $191,000 | -20.1% | 92,702 | -9.6% | 0.00% | – |
Q4 2021 | $239,000 | -35.6% | 102,571 | -3.8% | 0.00% | – |
Q3 2021 | $371,000 | -6.3% | 106,676 | +4.4% | 0.00% | – |
Q2 2021 | $396,000 | -76.8% | 102,163 | -72.5% | 0.00% | – |
Q1 2021 | $1,707,000 | -28.3% | 371,127 | -5.7% | 0.00% | – |
Q4 2020 | $2,381,000 | -64.7% | 393,548 | -4.0% | 0.00% | -100.0% |
Q3 2020 | $6,737,000 | -31.6% | 409,810 | -3.0% | 0.00% | -50.0% |
Q2 2020 | $9,851,000 | +78.6% | 422,434 | +13.6% | 0.00% | 0.0% |
Q1 2020 | $5,516,000 | -9.0% | 371,904 | +25.5% | 0.00% | +100.0% |
Q4 2019 | $6,063,000 | +106.7% | 296,339 | -0.7% | 0.00% | 0.0% |
Q3 2019 | $2,933,000 | -22.8% | 298,399 | +6.0% | 0.00% | 0.0% |
Q2 2019 | $3,797,000 | -33.7% | 281,470 | -3.3% | 0.00% | 0.0% |
Q1 2019 | $5,729,000 | -11.3% | 290,946 | +1.9% | 0.00% | -50.0% |
Q4 2018 | $6,458,000 | -40.5% | 285,455 | -2.3% | 0.00% | -33.3% |
Q3 2018 | $10,853,000 | +14.8% | 292,237 | +21.2% | 0.00% | +50.0% |
Q2 2018 | $9,456,000 | -13.7% | 241,163 | +8.1% | 0.00% | -33.3% |
Q1 2018 | $10,958,000 | +10.0% | 223,000 | +1.3% | 0.00% | 0.0% |
Q4 2017 | $9,959,000 | +49.4% | 220,096 | +15.3% | 0.00% | +50.0% |
Q3 2017 | $6,668,000 | +65.3% | 190,956 | -2.2% | 0.00% | +100.0% |
Q2 2017 | $4,033,000 | +160.2% | 195,321 | +221.2% | 0.00% | – |
Q1 2017 | $1,550,000 | +154.5% | 60,808 | +21.2% | 0.00% | – |
Q4 2016 | $609,000 | +108.6% | 50,153 | +24.0% | 0.00% | – |
Q3 2016 | $292,000 | +32.7% | 40,451 | +2.3% | 0.00% | – |
Q2 2016 | $220,000 | -75.0% | 39,550 | -77.4% | 0.00% | – |
Q1 2016 | $880,000 | -33.0% | 175,269 | +0.3% | 0.00% | – |
Q4 2015 | $1,313,000 | -17.9% | 174,719 | +4.4% | 0.00% | -100.0% |
Q3 2015 | $1,599,000 | +142.3% | 167,293 | +388.5% | 0.00% | – |
Q2 2015 | $660,000 | – | 34,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,943,164 | $75,021,000 | 18.96% |
ACUTA CAPITAL PARTNERS, LLC | 1,100,000 | $28,039,000 | 6.65% |
Avoro Capital Advisors LLC | 696,409 | $17,751,000 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,098,000 | 1.21% |
Perceptive Advisors | 664,354 | $16,934,000 | 0.96% |
Rock Springs Capital Management LP | 390,000 | $9,941,000 | 0.57% |
QVT Financial LP | 694,817 | $15,649,000 | 0.49% |
Orbimed Advisors | 1,257,300 | $32,049,000 | 0.36% |
Lyon Street Capital, LLC | 30,093 | $767,000 | 0.31% |
THOMPSON DAVIS & CO., INC. | 3,125 | $80,000 | 0.11% |